|
- PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan)
Learn more information about PLUVICTO, available before chemotherapy for the treatment of PSMA+ mCRPC See full Prescribing and Safety Information
- What Is PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan)?
Learn how PLUVICTO, the first and only radioligand therapy (RLT) for PSMA+ mCRPC, works as a targeted treatment See full Prescribing and Safety Info
- What to Expect With PLUVICTO Treatment
Learn about safety precautions what to expect when taking PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) injection See full Prescribing Safety Info
- Frequently Asked Questions I PLUVICTO
Find a list of answers to frequently asked questions about PSMA+ mCRPC and treatment with PLUVICTO See full Prescribing and Safety Information
- How PLUVICTO May Help
View the response to treatment with PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) injection in two clinical studies See full Prescribing Safety Info
- Treatment Center Locator I PLUVICTO
Access the locator to find the nearest PLUVICTO® (Lutetium Lu 177 vipivotide tetraxetan) treatment center See full Prescribing and Safety Information
- PLUVICTO Side Effects
Find information about the side effects of treatment with PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) injection See full Prescribing Safety Info
- Novartis Patient Support I PLUVICTO
Access patient support resources for treatment with PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) injection See full Prescribing and Safety Information
|
|
|